Zhejiang Ausun Pharmaceutical Co (SHSE:603229) E10: ¥0.18 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603229 Zhejiang Ausun Pharmaceutical Co Ltd SHSE:603229
83 GF Score
Price ¥8.09
GF Value ¥10.22
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Zhejiang Ausun Pharmaceutical Co E10?

Zhejiang Ausun Pharmaceutical Co SHSE:603229 83 E10 is ¥0.18 as of Mar. 2026. GuruFocus rates SHSE:603229 with a GF Score™ of 83/100 and a GF Value™ of ¥10.22 (Modestly Undervalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Zhejiang Ausun Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was ¥0.120. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.18 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-13), Zhejiang Ausun Pharmaceutical Co's current stock price is ¥8.09. Zhejiang Ausun Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was ¥0.18. Zhejiang Ausun Pharmaceutical Co's Shiller PE Ratio of today is 44.94.

During the past 13 years, the highest Shiller PE Ratio of Zhejiang Ausun Pharmaceutical Co was 68.39. The lowest was 42.56. And the median was 52.59.


Zhejiang Ausun Pharmaceutical Co  (SHSE:603229) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Zhejiang Ausun Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=8.09/0.18
=44.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Zhejiang Ausun Pharmaceutical Co was 68.39. The lowest was 42.56. And the median was 52.59.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Zhejiang Ausun Pharmaceutical Co E10 Related Terms


Zhejiang Ausun Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Zhejiang Ausun Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Ausun Pharmaceutical Co E10 Chart

Zhejiang Ausun Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.17 0.17

Zhejiang Ausun Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.18 0.18 0.17 0.18

SHSE:603229 vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Zhejiang Ausun Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Ausun Pharmaceutical Co Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhejiang Ausun Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Ausun Pharmaceutical Co's Shiller PE Ratio falls into.


SHSE:603229
83GF Score
Zhejiang Ausun Pharmaceutical Co Ltd SHSE:603229
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Ausun Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhejiang Ausun Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.12/116.3033*116.3033
=0.120

Current CPI (Mar. 2026) = 116.3033.

Zhejiang Ausun Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.015 101.400 0.017
201609 0.024 102.400 0.027
201612 0.043 102.600 0.049
201703 0.022 103.200 0.025
201706 0.020 103.100 0.023
201709 0.009 104.100 0.010
201712 0.030 104.500 0.033
201803 0.002 105.300 0.002
201806 0.029 104.900 0.032
201809 0.011 106.600 0.012
201812 0.015 106.500 0.016
201903 0.011 107.700 0.012
201906 0.032 107.700 0.035
201909 0.027 109.800 0.029
201912 0.009 111.200 0.009
202003 0.027 112.300 0.028
202006 0.033 110.400 0.035
202009 0.018 111.700 0.019
202012 0.029 111.500 0.030
202103 0.055 112.662 0.057
202106 0.052 111.769 0.054
202109 0.031 112.215 0.032
202112 0.046 113.108 0.047
202203 0.092 114.335 0.094
202206 0.066 114.558 0.067
202209 0.069 115.339 0.070
202212 0.071 115.116 0.072
202303 0.114 115.116 0.115
202306 0.080 114.558 0.081
202309 0.078 115.339 0.079
202312 0.040 114.781 0.041
202403 0.140 115.227 0.141
202406 0.080 114.781 0.081
202409 0.060 115.785 0.060
202412 -0.030 114.893 -0.030
202503 0.140 115.116 0.141
202506 0.060 114.907 0.061
202509 0.050 115.471 0.050
202512 -0.090 115.832 -0.090
202603 0.120 116.303 0.120

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ¥0.18 mean?
Zhejiang Ausun Pharmaceutical Co (SHSE:603229) has a E10 of ¥0.18 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Zhejiang Ausun Pharmaceutical Co and its competitors.
Is Zhejiang Ausun Pharmaceutical Co's E10 too high?
Zhejiang Ausun Pharmaceutical Co's current E10 is ¥0.18. Overall, Zhejiang Ausun Pharmaceutical Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Ausun Pharmaceutical Co's E10 compare to VRTX and REGN?
Zhejiang Ausun Pharmaceutical Co's E10 of ¥0.18 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Zhejiang Ausun Pharmaceutical Co and its competitors. Zhejiang Ausun Pharmaceutical Co's current E10 is ¥0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Ausun Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Ausun Pharmaceutical Co (SHSE:603229) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥10.22, compared to a current price of ¥8.09 — trading 20.8% below its estimated fair value. The current E10 is ¥0.18. Zhejiang Ausun Pharmaceutical Co's overall GF Score™ is 83/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Zhejiang Ausun Pharmaceutical Co (SHSE:603229), the current E10 is ¥0.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Ausun Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥8.09 is trading 20.8% below its estimated GF Value™ of ¥10.22. GuruFocus considers Zhejiang Ausun Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:603229:

  • E10: ¥0.18
  • GF Value™: ¥10.22 vs. price of ¥8.09 (20.8% below fair value)
  • GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the SHSE:603229 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhejiang Ausun Pharmaceutical Co Business Description

Address No.5, Donghai 4th Avenue, chemical raw materials base Linhai Park East, Zhejiang Province, Taizhou, CHN, 317016
Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.
83GF Score

Get the complete analysis for SHSE:603229

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.09
Price
¥10.22
GF Value